Results 111 to 120 of about 429,593 (156)

Inhibition of Interleukin-33 to Reduce Glomerular Endothelial Inflammation in Diabetic Kidney Disease. [PDF]

open access: yesKidney Int Rep
Hofherr A   +15 more
europepmc   +1 more source

P2X7 Receptor-Induced Human Mast Cell Degranulation Is Enhanced by Interleukin 33. [PDF]

open access: yesInt J Mol Sci
Salcman B   +5 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Interleukin-33 in health and disease

Nature Reviews Immunology, 2016
Interleukin-33 (IL-33) - a member of the IL-1 family - was originally described as an inducer of type 2 immune responses, activating T helper 2 (TH2) cells and mast cells. Now, evidence is accumulating that IL-33 also potently stimulates group 2 innate lymphoid cells (ILC2s), regulatory T (Treg) cells, TH1 cells, CD8+ T cells and natural killer (NK ...
Foo Yew Liew, Jean-Philippe Girard
exaly   +3 more sources

Interleukin-1 superfamily member, interleukin-33, in periodontal diseases

Biotechnic & Histochemistry, 2013
Interleukin (IL) -33 is a nuclear protein that is released from damaged cells and acts as an alarmin. We investigated the expression of IL-33 in human gingival fibroblasts after stimulation by tumor necrosis factor alpha (TNF-α). Human periodontal tissue samples were collected and fixed in phosphate-buffered 4% formalin in saline and processed to ...
A, Beklen, G, Tsaous Memet
openaire   +2 more sources

Home - About - Disclaimer - Privacy